RBC Capital Reaffirms Their Buy Rating on Boston Scientific (BSX)
4 days ago · In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $105.00. The …
RBC Capital holds Boston Scientific stock Outperform rating
4 days ago · Analysts at RBC Capital are particularly optimistic about Boston Scientific's growth prospects, noting an increasing weighted average market growth rate (WAMGR), which is …
RBC Capital on Boston Scientific (BSX): 'Consistent Top …
3 days ago · RBC Capital analyst Shagun Singh reiterated an Outperform rating and $105.00 price target on Boston Scientific (NYSE: BSX).The analyst commented: "BSX: Consistent Top …
RBC Capital holds Boston Scientific stock Outperform rating
4 days ago · Friday - In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with a steady price target of $105.00. The …
RBC Capital raises Boston Scientific stock target, maintains …
Apr 25, 2024 · On Monday, RBC Capital Markets adjusted its outlook on Boston Scientific Corporation (NYSE: BSX), a leading medical device manufacturer. The firm increased the …
RBC Capital Remains a Buy on Boston Scientific (BSX)
Nov 18, 2024 · RBC Capital analyst Shagun Singh Chadha reiterated a Buy rating on Boston Scientific (BSX – Research Report) on November 16 and set a price targ...
RBC Capital Maintains Boston Scientific (BSX) Outperform
Fintel reports that on September 21, 2023, RBC Capital maintained coverage of Boston Scientific (NYSE:BSX) with a Outperform recommendation.
Boston Scientific on Track to Be Highest Performing Medtech Firm, RBC …
3 days ago · Boston Scientific on Track to Be Highest Performing Medtech Firm, RBC Says 01:18pm: MT Boston Scientific Corporation Presents at 43rd Annual J.P. Morgan Healthcare …
RBC Capital maintient la note Surperformance pour l'action Boston ...
4 days ago · Vendredi - Dans une récente mise à jour, les analystes de RBC Capital ont maintenu leur note Surperformance sur les actions de Boston Scientific (NYSE:BSX), avec un objectif …
RBC Capital Adjusts Price Target on Boston Scientific to $95 …
-- Boston Scientific has an average rating of outperform and price targets ranging from $78 to $100, according to analysts polled by Capital IQ. Price: 85.56, Change: +1.15, Percent …
- Some results have been removed